KE1 5g for Exogenous Ketosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Exogenous KetosisKE1 5g - DietarySupplement
Eligibility
18 - 25
All Sexes
What conditions do you have?
Select

Study Summary

This trial assesses the effects of two different ketone supplements on blood ketone and glucose levels in young adults.

Eligible Conditions
  • Exogenous Ketosis

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 2 hours

2 hours
3-Hydroxybutyrate
Supplement tolerability and acceptability

Trial Safety

Trial Design

5 Treatment Groups

KE1 5g
1 of 5
KE4 10g
1 of 5
KE4 5g
1 of 5
KE1 10g
1 of 5
Control placebo
1 of 5

Experimental Treatment

Non-Treatment Group

16 Total Participants · 5 Treatment Groups

Primary Treatment: KE1 5g · Has Placebo Group · N/A

KE1 5g
DietarySupplement
Experimental Group · 1 Intervention: KE1 5g · Intervention Types: DietarySupplement
KE4 10g
DietarySupplement
Experimental Group · 1 Intervention: KE 10g · Intervention Types: DietarySupplement
KE4 5g
DietarySupplement
Experimental Group · 1 Intervention: KE4 5g · Intervention Types: DietarySupplement
KE1 10g
DietarySupplement
Experimental Group · 1 Intervention: KE1 10g · Intervention Types: DietarySupplement
Control placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo drink · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 hours

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,433 Previous Clinical Trials
2,219,206 Total Patients Enrolled

Eligibility Criteria

Age 18 - 25 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able and willing to attend study visits (once every 3 days for ~2 weeks).
You have a BMI of 18.5-29.9.\n